• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Subscribe
  • facebook
  • instagram
  • RSS
  • RSMUS.com

The Real Economy Blog

Search

  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences
Home > Coronavirus > ISM manufacturing index declines in February

ISM manufacturing index declines in February

Mar. 2, 2020 by Jason Alexander

  • email
  • Twitter
  • Facebook
  • Linkedin

The Institute for Supply Management’s manufacturing index — a key gauge of U.S. factory activity — dropped to 50.1 in February from 50.9 a month earlier, falling slightly below economists’ expectations. Sluggish global growth amid the spread of the coronavirus was a factor in that drop.

Figures above 50 in the index indicate the manufacturing economy is expanding. So while the ISM’s manufacturing index (also known as the Purchasing Manager’s Index or PMI) remained in expansion territory last month, it was just barely so.

The impact of the virus outbreak has yet to be fully felt.

The ISM’s measure of new orders, typically tracked as a leading economic indicator, fell to 49.8 in February from 52 in January. The organization’s index for new export orders fell last month after accelerating to its highest level since September 2018 in January. Inventories dropped 2.3 points, to 46.5, hovering just above the 42-month low registered in November 2019.

Manufacturers reported paying less for raw materials and other inputs, and the factory employment index ticked up to 46.9 in February from 46.6 in January. This indicates employment remained in contraction territory in February for the seventh month in a row.

The manufacturing PMI was still in expansion, but barely…

What lies ahead?

The pullback in the ISM’s index was not consistent with a series of fairly upbeat readings on the manufacturing sector at the regional level. The recently released purchasing manager survey tracking the Chicago region rose to a six-month high in February, and there was a rebound in factory activity in the district that covers Texas as well.

That being said, the ISM report was soft and the decline shown in new orders, if sustained, suggests the index could reverse its January gains and continue downward in March. February may be the last month before the coronavirus takes its toll on the global supply chain; at the same time, the Boeing shutdown of its 737 Max production will hurt the domestic supply chain throughout the first quarter of the year. That impact is expected to show up in both hard and soft data.

We do not expect the PMI index to rise in the near-term, and we recommend that our clients focus on evaluating alternative supply chains and evaluating their business models while continuing to invest in their people and technology to get ahead in today’s challenging environment.

  • email
  • Twitter
  • Facebook
  • Linkedin

Related posts

  • ISM Manufacturing Index continues to contract

    The October ISM Manufacturing Index continued to contract in October, though it improved to 48.3 from September's reading of 47.9, implying a modestly slower pace of contraction in domestic manufacturing sentiment.

  • Latest ISM purchasing managers index signals potential recessionary territory for manufacturing sector

    A key gauge of U.S. factory activity contracted in August for the first time in three years, as new orders continued to stall. Performance of the ISM purchasing managers index highlights the repercussions of trade uncertainty and slower…

  • ISM manufacturing survey points toward further moderation

    Those looking for stabilization in the downward trajectory of U.S. manufacturing sentiment will have to wait until mid-year.The April 2019 Institute for Supply Management Report on Business – an important gauge of U.S. factories – arrived below expectations…

Filed Under: Coronavirus, Economics, Industrials Tagged With: coronavirus, ISM, ISM manufacturing index, manufacturing

About Jason Alexander

@jaalex53

Jason assists clients in the industrial products, consumer products and financial services industries and has more than 15 years of experience serving large multinational clients with particular emphasis on SEC clients, Fortune 500 and middle market companies. Jason has previously advised clients in the areas of accounting, risk management, mergers and acquisitions, process design and improvement, internal audit, regulatory compliance, internal and external financial reporting and information technology system implementation. Strong record of accomplishment of people, team and practice development across North America, Europe, Latin America, Africa and Asia.

Jason is also on the Board of Directors of the RSM US Foundation and a member of RSM’s cutting edge Industry Eminence Program, which positions participants to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves.

Primary Sidebar

Read RSM analysts’ industry coverage of coronavirus.

Categories

  • Economics
  • Technology
  • Consumer Products
  • Industrials
  • Financial Services
  • Real Estate
  • Health Care
  • Life Sciences

Recent Manufacturing articles

Recent Economics articles

  • CHART OF THE DAY: Manufacturing upturn strongest since 2014 Jan. 22, 2021
  • China’s economic power: You may not like it, but you cannot ignore it Jan. 22, 2021
  • Inflation-adjusted interest rates, investment and the middle market Jan. 22, 2021

RSMUS.com links

The Real Economy

Middle Market Business Index

MMBI Special Reports

Footer

  • Facebook
  • Instagram
  • RSS

About The Real Economy Blog

The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy. It is offered as a complement to RSM’s macroeconomic thought leadership, including The Real Economy monthly publication and the proprietary RSM US Middle Market Business Index (MMBI).

© 2021 RSMUS.com | Privacy Policy | Cookie Policy

The Real Economy Blog
  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences